Cervical Intraepithelial Neoplasia (cin) Test System

Device Code: 5028

Product Code(s): PRB

Definition: The P16 CIN Test System Is A Qualitative Immunohistochemistry (IHC) Test To Assess The P16INK4a Protein In Formalin-fixed, Paraffin-embedded (FFPE) Cervical Punch Biopsy Tissues. It Is Indicated As An Adjunct To Examination Of Hematoxylin And Eosin (

Device Classification Information

Device Type ID5028
Device NameCervical Intraepithelial Neoplasia (cin) Test System
Physical StateThe Device May Include A Primary Antibody And Accessory Reagents Or Other Detection System.
Technical MethodThe Test Uses A Primary Antibody, Specific Reagents Or Methods To Detect P16INK4a Protein In Human Clinical Specimens. May Include Antibody-antigen Protein Complexes, Which Are Visualized Using An Enzyme Conjugated Antibody Or Other Detection Systems
Target AreaHuman Clinical Specimens
Regulation DescriptionCervical Intraepithelial Neoplasia (CIN) Test System.
Regulation Medical SpecialtyPathology
Review PanelPathology
Premarket Review Office Of In Vitro Diagnostics And Radiological Health (OIR)
Submission Type510(k)
CFR Regulation Number864.1865 [🔎]
FDA Device ClassificationClass 2 Medical Device
Product CodePRB
GMP ExemptNo
Summary MRIneligible
Implanted DeviceNo
Life Support DeviceNo
Third Party Review Not Third Party Eligible

Recognized Standards

Total Product Life Cycle

Device Type ID5028
DeviceCervical Intraepithelial Neoplasia (cin) Test System
Product CodePRB
FDA Device ClassificationClass 2 Medical Device
Regulation DescriptionCervical Intraepithelial Neoplasia (CIN) Test System.
CFR Regulation Number864.1865 [🔎]
Recalls
Manufacturer Recall Class Date Posted
1
Ventana Medical Systems Inc
I Sep-14-2018
TPLC Last Update: 2019-04-02 20:59:03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.